Agilon Health (NYSE:AGL) Shares Gap Down – Here’s Why

Agilon Health, Inc. (NYSE:AGL) shares gapped down prior to trading on Tuesday . The stock had previously closed at $92.54, but opened at $86.85. Agilon Health shares last traded at $89.06, with a volume of 8,165 shares.

Wall Street Analysts Forecast Growth

AGL has been the topic of several recent analyst reports. Truist Financial set a $112.00 price target on Agilon Health and gave the company a “hold” rating in a research note on Thursday, August 6th. Citigroup upgraded Agilon Health from a “sell” rating to a “neutral” rating and increased their price objective for the company from $105.00 to $115.00 in a research note on Monday, August 10th. TD Cowen reiterated a “hold” rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Finally, Barclays set a $111.00 target price on shares of Agilon Health and gave the company an “equal weight” rating in a research report on Thursday, August 6th. Five investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $97.70.

Agilon Health Price Performance

The company has a market cap of $1.47 billion, a price-to-earnings ratio of -6.12 and a beta of 3.02. The company’s 50 day moving average price is $102.75 and its 200 day moving average price is $65.53. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. Equities research analysts forecast that Agilon Health, Inc. will post -2.33 earnings per share for the current year.

Institutional Investors Weigh In On Agilon Health

Several institutional investors have recently modified their holdings of the company. AQR Capital Management LLC boosted its position in Agilon Health by 243.3% during the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after purchasing an additional 355,365 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Agilon Health by 3.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after acquiring an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd boosted its stake in shares of Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after acquiring an additional 10,424 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Agilon Health by 6.6% during the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after acquiring an additional 311,158 shares during the last quarter. Finally, Creative Planning increased its position in Agilon Health by 17.6% during the 2nd quarter. Creative Planning now owns 170,969 shares of the company’s stock worth $393,000 after purchasing an additional 25,548 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.